18 results with keyword: 'aplastic nivolumab treatment allogeneic hematopoietic transplantation myeloid leukemia'
Aplastic Anemia induced by Nivolumab before a Treatment of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.. Wenhan Cheng ,
N/A
Keywords: myelodysplastic syndrome, acute myeloid leukemia, Decitabine, transplantation conditioning, graft versus host disease, allogeneic hematopoietic stem cell
N/A
Allogeneic hematopoietic cell transplantation (allo-HCT) is an important and widely used treatment for patients with hematological malignancies, including Acute Myeloid Leukemia
N/A
A substantial body of published evidence supports the use of allogeneic hematopoietic stem-cell transplantation (HSCT) as consolidation treatment for acute myeloid leukemia
N/A
AHSCT: Allogeneic hematopoietic stem cell transplantation; ALL: Acute lymphoid leukemia; AML: Acute myeloid leukemia; BM: Bone marrow; CpGs: Cytosines adjacent to guanines;
N/A
ALL: acute lymphoblastic leukemia; allo-HSCT: allogeneic hematopoietic cell transplantation; AUC: area under the curve; AML: acute myeloid leukemia; BM: bone marrow; CR:
N/A
aGVHD: Acute graft-versus-host disease; ALL: Acute lymphoid leukemia; allo- HSCT: Allogeneic hematopoietic stem cell transplantation; AML: Acute myeloid leukemia; DRI: Disease
N/A
95% CI: 95% cumulative incidence; ALL: Acute lymphoid leukemia; allo- HSCT: Allogeneic hematopoietic stem cell transplantation; AML: Acute myeloid leukemia; ANC: Absolute
N/A
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the preferred treatment to consolidate remission in (very) poor-risk patients with acute myeloid leukemia (AML)..
N/A
AML: acute myeloid leukemia; CR: complete remission; CR1: first complete remission; Allo-HSCT: allogeneic hematopoietic stem cell transplantation; HD: healthy donor; PBMCs:
N/A
Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research
N/A
Introduction: Allogeneic hematopoietic stem cell transplantation (ASCT) repre- sents a potentially curative approach for patients with relapsed or refractory acute myeloid
N/A
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the
N/A
AlloHSCT: Allogeneic hematopoietic stem cell transplantation; AML: Acute myeloid leukemia; AraC: Cytarabine; DNAM-1: DNAX accessory molecule 1; DNR: Daunorubicin; DNTs: Double
N/A
ADOPT, Alternative Dosing for Outpatient Treatment; allogeneic HCT, allogeneic hematopoietic cell transplanta- tion; AML, acute myeloid leukemia; AZA, 5-azacitidine; BSC,
N/A
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report
N/A
Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia.
N/A
aGVHD: Acute graft-versus-host disease; allo-SCT: Allogeneic hematopoietic stem cell transplantation; AML: Acute myeloid leukemia; ANC: Absolute nuclear cells; ATG:
N/A